Current Medicinal Chemistry - Cardiovascular & Hematological Agents

Role of Calmodulin in Platelet Receptor Function
pp. 283-287(5)
Authors: Gardiner, E. E.; Arthur, J. F.; Berndt, M. C.; Andrews, R. K.

Homocysteine-Lowering Treatment in Coronary Heart Disease
pp. 289-295(7)
Authors: Cesari, M.; Rossi, G. P.; Pessina, A. C.

Anemia in Chronic Heart Failure - Clinical and Prognostic Significance
pp. 297-303(7)
Authors: Karhausen, T.; Anker, S. D.; Doehner, W.

Recent Progress in Signal Transduction Research of the Angiotensin II Type-1 Receptor: Protein Kinases, Vascular Dysfunction and Structural Requirement
pp. 305-322(18)
Authors: Suzuki, H.; Motley, E. D.; Frank, G. D.; Utsunomiya, H.; Eguchi, S.

Strategic Leukofiltration in Cardiac Surgery
pp. 323-331(9)
Authors: Gunaydin, S.; McCusker, K.; Vijay, V.

Modulators of Ion Channels Activated by Hypotonic Swelling in Cardiomyocytes: New Perspectives for Pharmacological Treatment of Life-Threatening Arrhythmias
pp. 333-339(7)
Author: Kocic, I.

Fibrinolysis at the Fluid-Solid Interface of Thrombi
pp. 341-355(15)
Authors: Kolev, K.; Longstaff, C.; Machovich, R.

Pharmacogenetics in Cardiovascular Antithrombotic Therapy
pp. 357-364(8)
Authors: Marin, F.; Roldan, V.; Gonzalez-Conejero, R.; Corral, J.

Thrombocytopenia in HIV Disease: Clinical Relevance, Physiopathology and Management
pp. 365-376(12)
Authors: Miguez-Burbano, M. J.; Jackson Jr., J.; Hadrigan, S.

Clinical Determination of the Severity of Metabolic Syndrome: Preheparin Lipoprotein Lipase Mass as a New Marker of Metabolic Syndrome
pp. 377-381(5)
Authors: Miyashita, Y.; Shirai, K.

Angiotensin-(1-7): Blood, Heart, and Blood Vessels
pp. 383-391(9)
Authors: Santos, R. A.S.; Frezard, F.; Ferreira, A. J.